AAPL $274.33 +1.24% MSFT $400.66 -0.93% GOOGL $320.92 -1.35% AMZN $223.93 +0.47% NVDA $175.63 +1.43% TSLA $397.19 -0.83% META $668.84 -1.32% JPM $312.48 -1.32% V $332.83 +0.00% WMT $128.56 +0.95% AAPL $274.33 +1.24% MSFT $400.66 -0.93% GOOGL $320.92 -1.35% AMZN $223.93 +0.47% NVDA $175.63 +1.43% TSLA $397.19 -0.83% META $668.84 -1.32% JPM $312.48 -1.32% V $332.83 +0.00% WMT $128.56 +0.95%

SmartInvestorsDaily

NASDAQ: TLRY

Tilray Brands, Inc.

Healthcare • Drug Manufacturers - Specialty & Generic • www.tilray.com

$7.33 $-0.27 (-3.54%)

As of Feb 5, 3:01 PM UTC

Market Cap $946.21M

P/E Ratio -0.30

Dividend Yield 0.00%

Volume 443,936

Avg Volume 7,172,365

52-Week High N/A

52-Week Low N/A

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.

N/A Based on 0 analysts

Avg Price Target $2.00 (-72.7% upside)

Tilray Has Already Done The Hard Part

SeekingAlpha • 1 week ago

Tilray: Rescheduling Rally Meets Equity Erosion & Short Interest Volatility

SeekingAlpha • 1 week ago

International Cannabis Expansion Gives Tilray Positive 2026 Outlook

SeekingAlpha • 4 weeks ago

Tilray Brands, Inc. (TLRY) Q2 2026 Earnings Call Transcript

SeekingAlpha • 4 weeks ago

Stock Market Today: Dow Futures Gain, Nasdaq Slips Despite Trump Executive Order On AI—Broadcom, Lululemon, Tilray In Focus

benzinga.com • 2 months ago

FEATURED BY

Barron's

Forbes

Inc.

Nasdaq

Seeking Alpha